Betadine vs Chlorhexidine for Preoperative Skin Prep

Chlorhexidine and betadine (povidone-iodine) are the two most widely used antiseptics in modern healthcare, and neither is universally superior. Chlorhexidine tends to outperform povidone-iodine for preoperative skin preparation and central venous catheter care, while povidone-iodine holds clear advantages around the eyes, ears, and other sensitive tissues. The choice between them depends on where on the body you’re using them, what kind of procedure is involved, and the patient’s allergy history.

How They Kill Germs Differently

Povidone-iodine works by releasing molecular iodine, which attacks multiple targets inside microbial cells simultaneously. The polymer (polyvinylpyrrolidone) acts as a carrier, slowly releasing free iodine into solution where it can reach the membranes of bacteria, viruses, and fungi.¹ This multi-target approach is one reason resistance to iodine-based antiseptics remains rare even after decades of use.

Chlorhexidine takes a different route. It carries a positive charge that is attracted to the negatively charged surface of bacterial cells. Once it latches on, it punches through the cell wall and damages the inner membrane, causing the cell’s contents to leak out.² Research on E. coli has confirmed that this membrane disruption, rather than enzyme inhibition, is what actually kills the bacteria.³

A practical difference flows from their chemistry: chlorhexidine binds to skin proteins and keeps working for hours after application, a property called substantivity. Povidone-iodine does not bind the same way, so its antimicrobial activity fades once the solution dries or is wiped away. That lingering activity is one reason chlorhexidine performs well in settings where prolonged skin contact matters, like catheter dressings.

Preoperative Skin Preparation

For cleaning skin before a surgical incision, chlorhexidine generally comes out ahead. A landmark trial published in the New England Journal of Medicine compared chlorhexidine-alcohol with aqueous povidone-iodine in clean-contaminated abdominal surgeries and found that the surgical-site infection rate was roughly 10% in the chlorhexidine group versus 16% in the povidone-iodine group. Chlorhexidine was significantly more protective against both superficial and deep incisional infections, though not against organ-space infections deeper inside the body.⁴

A meta-analysis of clean-contaminated surgeries reinforced that picture, finding that chlorhexidine reduced the odds of surgical-site infection by about a third compared with povidone-iodine.⁵ A network meta-analysis of clean surgeries ranked higher-concentration chlorhexidine preparations as the most effective antiseptic option overall.⁶

That said, a large international pragmatic trial (FALCON) that included thousands of patients across multiple countries found no statistically significant difference in surgical-site infection rates between alcoholic chlorhexidine and aqueous povidone-iodine, with rates of about 18% and 20% respectively.⁷ The FALCON trial enrolled patients in low- and middle-income countries as well as high-income settings, which may explain the higher baseline infection rates and the narrower gap. The bottom line for surgical skin prep is that chlorhexidine has a consistent edge, but the advantage is more pronounced in some populations and procedure types than others.

Central Lines and Catheter Sites

If there is one clinical setting where chlorhexidine dominates, it is catheter-site care. A meta-analysis of studies involving central vascular catheters found that chlorhexidine cut the risk of catheter-related bloodstream infections by about half compared with povidone-iodine.⁸ Individual trials have confirmed this. One study reported catheter colonization rates of about 12% with chlorhexidine versus 22% with povidone-iodine, and use of povidone-iodine was itself identified as an independent risk factor for colonization.⁹

The concentration of chlorhexidine matters. A multicenter study found that 2% chlorhexidine in alcohol roughly halved catheter-related infections compared with alcoholic povidone-iodine, but lower-concentration chlorhexidine solutions did not produce a statistically significant benefit.¹⁰ The French CLEAN trial found an even more dramatic difference, with catheter-related infection rates of 0.28 per 1,000 catheter-days for chlorhexidine-alcohol versus 1.77 for povidone-iodine-alcohol.¹¹ Chlorhexidine’s ability to bind to skin and continue killing bacteria between dressing changes likely explains why it performs so well here.

Joint Replacement and Orthopedic Surgery

In joint replacement, the picture is less clear-cut. A study comparing intraoperative betadine wash to chlorhexidine wash during hip and knee arthroplasty found no significant difference in rates of periprosthetic joint infection or return trips to the operating room.¹² A more recent meta-analysis of irrigation solutions used during total joint arthroplasty confirmed this: both povidone-iodine and chlorhexidine reduced the risk of periprosthetic joint infection by about 40% compared with saline, but neither was significantly better than the other.¹³

That equivalence, combined with the fact that povidone-iodine is substantially cheaper, has led some orthopedic teams to favor betadine for joint lavage. When the antiseptic is being used to irrigate an open wound cavity rather than prepare intact skin, chlorhexidine’s substantivity advantage matters less, and cost becomes a bigger consideration.

Where Betadine Has a Clear Safety Edge

Chlorhexidine is toxic to the ears, meninges, and eyes, and most guidelines flatly recommend against using it near these structures. A review of antiseptic-related ocular injuries in surgical settings concluded that povidone-iodine is the recommended antiseptic for ophthalmic and head-and-neck surgeries close to the eye.¹⁴ Systematic review of ototoxic antiseptics found that iodine-based solutions cause the least harm to ear structures, while chlorhexidine and high-concentration alcohol solutions cause the most.¹⁵

There is an interesting wrinkle, though. A study of conjunctival goblet cells found that povidone-iodine and betadine were actually more cytotoxic to those specific cells than chlorhexidine was, with goblet cell survival around 23% after povidone-iodine exposure versus about 78% after chlorhexidine.¹⁶ This does not override the broader safety data: chlorhexidine’s risks around the eye come from potential corneal toxicity and keratitis, not from effects on goblet cells specifically. Still, the finding suggests that the nuances of ophthalmic antisepsis are far from settled, and formulation details matter.

Tissue Toxicity at Clinical Concentrations

Both antiseptics are tough on human tissue, not just bacteria. In lab studies, povidone-iodine and chlorhexidine at their standard clinical concentrations killed the vast majority of human fibroblasts and skin cells within seconds. Fibroblast survival after just five seconds of contact with povidone-iodine was essentially zero, and chlorhexidine was only marginally gentler.¹⁷

Chlorhexidine may be more damaging to deeper tissue types. A study exposing fibroblasts, muscle cells, and bone cells to various chlorhexidine dilutions found that any concentration at or above 0.02% left fewer than 6% of cells alive regardless of exposure time. The clinically used concentration of 2% permanently halted cell migration and severely reduced survival of all three cell types.¹⁸ An older study using canine fibroblasts found a similar dilemma: every concentration of either antiseptic that was strong enough to kill bacteria was also lethal to fibroblasts.¹⁹

This is why surgeons are cautious about pouring antiseptics into open wounds or joint spaces at full strength. Dilute solutions are the norm for irrigation, and the balance between antimicrobial activity and tissue damage is a running theme in the research.

Biofilm Performance

Both antiseptics struggle against biofilms, the slimy bacterial communities that form on implanted devices and dead tissue. A study testing povidone-iodine, hydrogen peroxide, and chlorhexidine against Staphylococcus aureus biofilms on implant materials found that none of them achieved the threshold for true bactericidal activity. They reduced bacterial counts compared to untreated surfaces, but did not come close to eradicating the biofilm.²⁰

Both agents can prevent biofilms from forming in the first place at low concentrations, but paradoxically, very dilute concentrations can actually increase biofilm formation.²¹ This finding is a cautionary note about the importance of proper concentration: using too little antiseptic might make things worse.

Organic Matter and Real-World Conditions

Both antiseptics lose effectiveness in the presence of blood, pus, and other organic material, but this affects them in somewhat different ways. Lab testing shows that organic contamination reduces the antimicrobial activity of both povidone-iodine and chlorhexidine, sometimes requiring ten-fold higher concentrations to achieve the same bacterial kill.²²²³ Povidone-iodine is often described as being more susceptible to inactivation by blood and serum than chlorhexidine, though both are compromised. In practice, this means that thorough cleaning of the surgical site before applying either antiseptic is critical.

Allergy and Hypersensitivity Profiles

Both antiseptics can cause allergic reactions, but the patterns differ. Povidone-iodine has a reputation for good allergenicity profile: true allergic contact dermatitis is uncommon, though practitioners often confuse irritant reactions with allergic ones.²⁴ A common misconception is that people with shellfish allergies cannot receive betadine. Shellfish allergy is caused by proteins in shellfish, not by iodine, and there is no cross-reactivity with povidone-iodine.

Chlorhexidine is considered a relatively weak allergen, but it can occasionally trigger immunologic contact urticaria and, rarely, life-threatening anaphylaxis.²⁵ A 20-year analysis of the FDA’s adverse event reporting system found over 12,600 hypersensitivity reports involving chlorhexidine versus about 3,000 for povidone-iodine. Roughly 3.5% of the chlorhexidine reports involved anaphylaxis. Reports of chlorhexidine-related hypersensitivity have been rising sharply, with urticaria cases accelerating the fastest, likely reflecting increased use in healthcare settings over the past two decades.²⁶

The practical takeaway: if you’ve had a reaction to chlorhexidine, povidone-iodine is usually a safe alternative and vice versa. True cross-reactivity between the two is not a recognized problem. Healthcare workers should document chlorhexidine allergy status just as they would for any other drug allergy, because intraoperative anaphylaxis to chlorhexidine can be difficult to diagnose in real time.

Thyroid Concerns with Povidone-Iodine

One unique downside of betadine is that iodine can be absorbed through the skin and mucous membranes. In most cases, this absorption is clinically insignificant. A study of patients who received dilute povidone-iodine irrigation during orthopedic surgery found that urinary iodine levels spiked to high levels in the early postoperative period but returned toward baseline within two weeks, and thyroid function tests did not show statistically significant changes.²⁷

However, prolonged or extensive use tells a different story. In one case, a patient receiving weeks of betadine wound care for large wounds developed clinically significant hypothyroidism, with TSH levels four times the upper limit of normal and very high urinary iodine levels exceeding 10,000 micrograms per liter.²⁸ Neonates and patients with existing thyroid conditions are particularly vulnerable. Chlorhexidine has no analogous endocrine risk, which is one reason some burn units and neonatal intensive care units prefer it for prolonged antiseptic use.

Cost and Health-System Economics

Povidone-iodine costs a fraction of what chlorhexidine does per unit volume. But because chlorhexidine tends to prevent more infections, the cost calculus often reverses when you factor in the expense of treating those infections. A systematic review and cost analysis estimated that switching from iodine to chlorhexidine for preoperative skin antisepsis would save roughly $16 to $26 per surgical case, adding up to hundreds of thousands of dollars per year at a large hospital.²⁹

A European analysis estimated that chlorhexidine with 70% ethanol prevented about 8 additional infections per 1,000 patients compared with povidone-iodine with ethanol, generating net cost savings of roughly €152,000 per 1,000 patients.³⁰ For catheter-site care, the economics are even more favorable: a decision-analysis model estimated savings of about $113 per catheter used when chlorhexidine replaced povidone-iodine, driven by a decrease in bloodstream infections and related deaths.³¹

Where the two antiseptics perform equally, as in joint replacement irrigation, the math flips: betadine’s lower unit cost makes it the more rational choice when clinical outcomes are the same.

Resistance Concerns

Resistance to povidone-iodine remains essentially nonexistent because iodine attacks so many cellular targets at once that bacteria cannot easily evolve their way out. Chlorhexidine resistance is more concerning. It is rarely seen in common organisms like E. coli or Staphylococcus aureus, but it shows up more frequently in species like Enterobacter, Pseudomonas, Proteus, and Enterococcus. Chlorhexidine resistance has also been detected in multidrug-resistant strains of Klebsiella pneumoniae.³² As chlorhexidine use in hospitals has expanded, some researchers have called for an “antiseptic stewardship” approach similar to antibiotic stewardship, to slow the development of resistance by using chlorhexidine judiciously rather than as a blanket default.

Environmental Persistence

Chlorhexidine is a persistent compound in the environment. It survives wastewater treatment and accumulates in sewage sludge. Testing of sludge from municipal treatment plants found chlorhexidine at concentrations high enough to kill common microorganisms like Candida albicans, E. coli, and S. aureus, potentially disrupting the microbial communities that treatment plants depend on. The compound did not appear to harm plant germination at measured soil concentrations, though.³³ Chlorhexidine also adsorbs onto sediments in waterways and has the potential to harm aquatic organisms at low concentrations, a concern given how widely it is now used.³⁴

Povidone-iodine breaks down more readily. The iodine it releases is a naturally occurring element that is metabolized and diluted in the environment without the same persistence concerns. This is not typically a factor in clinical decision-making, but as hospitals increase their use of chlorhexidine for everything from daily patient bathing to surface disinfection, the cumulative environmental load is worth watching.

Veterinary Applications

The betadine-versus-chlorhexidine debate extends to animal surgery. A systematic review and meta-analysis of preoperative skin preparation in veterinary surgery found no difference between the two agents in rates of surgical-site infection or skin bacterial reduction, either immediately after application or at later time points.³⁵ The evidence base in veterinary medicine is thinner than in human surgery, and many veterinary protocols are adapted from human guidelines rather than derived from species-specific trials. In practice, both antiseptics are used routinely in veterinary operating rooms, and the choice often comes down to institutional habit, cost, and the specific species and procedure involved.